Compounds > beta-lactams
Page last updated: 2024-09-04

beta-lactams and ciprofloxacin

beta-lactams has been researched along with ciprofloxacin in 104 studies

Compound Research Comparison

Studies
(beta-lactams)		Trials
(beta-lactams)		Recent Studies (post-2010)
(beta-lactams)		Studies
(ciprofloxacin)		Trials
(ciprofloxacin)		Recent Studies (post-2010) (ciprofloxacin)
7,5791793,39516,0601,3316,092

Protein Interaction Comparison

ProteinTaxonomybeta-lactams (IC50)ciprofloxacin (IC50)
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)0.41
DNA gyrase subunit BBacillus subtilis subsp. subtilis str. 1686.3
DNA gyrase subunit ABacillus subtilis subsp. subtilis str. 1686.3
Cytochrome P450 3A4Homo sapiens (human)0.31
DNA gyrase subunit BStaphylococcus aureus4.32
DNA gyrase subunit AEscherichia coli K-120.6845
DNA gyrase subunit BEscherichia coli K-120.5632
DNA topoisomerase 4 subunit BStaphylococcus aureus6.485
DNA topoisomerase 4 subunit AStaphylococcus aureus4.8011
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)0.41
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)0.41
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)0.41
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)0.41
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)0.41
DNA gyrase subunit AStaphylococcus aureus4.32
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)0.41
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)0.41
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)0.41
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)0.41
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)0.41
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)0.41
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)0.41
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)0.41
DNA topoisomerase 4 subunit ABacillus subtilis subsp. subtilis str. 1681.7
DNA topoisomerase 4 subunit BBacillus subtilis subsp. subtilis str. 1681.7
GABA theta subunitRattus norvegicus (Norway rat)0.41
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)0.41

Research

Studies (104)

TimeframeStudies, this research(%)All Research%
pre-199013 (12.50)18.7374
1990's12 (11.54)18.2507
2000's32 (30.77)29.6817
2010's32 (30.77)24.3611
2020's15 (14.42)2.80

Authors

AuthorsStudies
Bangsborg, J; Frimodt-Møller, N; Gutschik, E; Westh, H1
Gordon, CA; Hodges, NA1
Guenounou, M; Miguères, ML; Ronco, E1
Dornbusch, K1
Croize, J; Gout, JP; Le Noc, P; Robert, J1
Bartlett, KH; Chow, AW; Shafran, SD; Stiver, HG; Wong, J1
Chin, NX; Neu, HC1
Chau, PY; Leung, YK; Lolekha, S; Ng, WS1
Haller, I1
Liu, S; Meyer, RD2
Franke, JJ; Manion, FA; Stratton, CW; Weeks, LS1
Bartlett, KH; Chow, AW; Wong, J2
Gmeiner, J; Kroll, HP; Leying, H; Opferkuch, W; Suerbaum, S1
Karch, H; Kroll, HP; Leying, H; Opferkuch, W; Suerbaum, S1
Daikos, GL; Jackson, GG; Kathpalia, SB; Lolans, VT; Sharifi, R1
Appelbaum, PC; Jacobs, MR; Pankuch, GA; Rittenhouse, SF1
Hu, BS; Lau, YJ; Lin, YH; Liu, PY; Shi, ZY; Shyr, JM; Tsai, WS; Tseng, CY1
Andrews, JM; Brenwald, N; Wise, R1
Cavallo, JD; Dubrous, P; Fabre, R; Hernandez, E; Nordmann, P1
Bello, H; Dominguez, M; Garcia, A; Gonzalez, G; Mella, S; Zemelman, R1
Aguilar, C; Carnalla, N; Echániz, G; Estrada, MA; López-Antuñano, FJ; Silva, J; Soto, A1
Alperstein, P; France, K; Isenberg, HD1
Espasa, M; Gómez-Martínez, J; Jiménez de Anta, MT; Marco, F; Martínez, JA; Mensa, J1
Andriole, VT; Bassetti, M; Callan, DA; Dembry, LM; Farrel, PA1
Jones, RN; Pfaller, MA1
Carryn, S; Mingeot-Leclercq, MP; Tulkens, PM; Van Bambeke, F1
Bartizal, K; Gesser, RM; Motyl, M; Pelak, BA; Woods, GL1
Behra-Miellet, J; Dubreuil, L; Jumas-Bilak, E1
Gendrel, D; Lorrot, MM; Marc, E; Moulin, F; Ravilly, S; Raymond, J; Sauvé-Martin, H; Soulier, M1
Johnson, MM; Piddock, LJ; Webber, MA1
Harigae, H; Ishikawa, S; Kaku, M; Kanemitsu, K; Kunishima, H; Saga, T; Takemura, H1
Bertrand, X; Lallemand-De-Conto, S; Talon, D; Thouverez, M1
Bonten, MJ; Florijn, A; Fluit, AC; Nijssen, S; Schmitz, FJ; Verhoef, J1
Burgess, DS; Frei, CR; Moczygemba, LR1
Evangelista, AT; Jones, ME; Karlowsky, JA; Sahm, DF; Thornsberry, C; Yee, YC1
De Vecchi, E; Drago, L; Gismondo, MR; Nicola, L; Tocalli, L1
Leibovici, L; Paul, M1
Bliziotis, IA; Christodoulou, C; Chrysanthopoulou, S; Falagas, ME; Kasiakou, SK; Michalopoulos, A; Samonis, G1
Amicosante, G; Becerro, P; De Anta, MT; Perilli, M; Ruiz, J; Tavío, MM; Vila, J1
Lipman, J; Roberts, JA1
Bliziotis, IA; Falagas, ME; Matthaiou, DK; Peppas, G1
Devreese, K; Leus, B; Malfait, R; van den Bossche, J1
Momary, KM; Pai, MP; Rodvold, KA1
Li, JT; Markus, P; Matesic, D; Park, M1
Shinagawa, N; Takeyama, H; Taniguchi, M; Yura, J1
Galani, I; Giamarellos-Bourboulis, EJ; Giamarellou, H; Kanellakopoulou, K; Sarafis, P1
Berta, J; Damjanova, I; Füzi, M; Hajbel-Vékony, G; Jakab, M; Milch, H; Pászti, J; Tóth, A1
Ba, T; Gao, BQ; Li, YY; Ma, WH; Meng, ZY; Wang, LF; Wang, XD; Yu, QP; Zhang, J; Zhang, LH1
Amicosante, G; Celenza, G; Forcella, C; Frascaria, P; Pellegrini, C; Perilli, M; Segatore, B1
Basuino, L; Chambers, HF; Tattevin, P1
Almela, M; López, J; López-Dupla, M; Marco, F; Martínez, JA; Mensa, J; Olona, M; Soriano, A; Vidal, F1
Badri, M; Donaghy, P; Karisik, E; Livermore, DM; Loughrey, AC; McCalmont, M; O'Leary, MC; Rooney, PJ; Smyth, B; Woodford, N1
Ermertcan, S; Hosgor-Limoncu, M; Tasli, H; Yurtman, AN1
Ablij, HC; Assendelft, WJ; Blom, JW; Delfos, NM; Elzevier, HW; Koster, T; Kuijper, EJ; Leyten, EM; Pander, J; Spelt, IC; van Dissel, JT; van Nieuwkoop, C; van't Wout, JW; Wattel-Louis, GH1
Lee, HJ; Lee, KM; Suh, JT; Yang, HY1
Ikeda, F; Ishii, Y; Iyoda, T; Kanayama, A; Kobayashi, I; Matsuzaki, K; Saika, T; Yamaguchi, K1
Brandão, AP; Brandileone, MC; de Paiva, MV; Gorla, MC; Lemos, AP; Salgueiro, VC; Vázquez, JA1
Andersohn, F; Bronder, E; Garbe, E; Grüneisen, A; Hildebrandt, M; Klimpel, A; Kurtal, H; Mayer, B; Salama, A; Schrezenmeier, H; Späth-Schwalbe, E; Thomae, M1
Chiu, CH; Su, LH; Wu, TL1
Ezoe, T; Ishiyama, M; Matsumoto, K; Noguchi, K; Shiga, M; Suenaga, H; Tsukatani, T1
Gruszczyńska, B; Kaznowski, A; Mokracka, J1
Bonomo, RA; Donskey, CJ; Drawz, PE; Hirsch, AA; Jump, RL; Jury, LA; Kypriotakis, G; Olds, DM; Peron, EP; Seifi, N; Watts, B1
Bou, G; Castelo-Corral, L; Gutiérrez-Urbón, JM; Llinares, P; López-Calviño, B; Molina, F; Sousa, D1
Ciofu, O; Hengzuang, W; Høiby, N; Jensen, PØ; Jørgensen, KM; Molin, S; Wassermann, T1
Fabry, WH; Kock, HJ; Vahlensieck, W1
Belghiti, J; Bert, F; Dondero, F; Durand, F; Larroque, B; Moreau, R; Nicolas-Chanoine, MH; Paugam-Burtz, C1
Blackmore, T; Losco, G; Studd, R1
Bowler, IC; Buchanan, R; Crook, D; Stoesser, N1
Anderson, RC; Andrews, K; Beier, RC; Bodeis-Jones, S; Crippen, TL; Davidson, MK; Foley, SL; McDermott, PF; Nisbet, DJ; Poole, TL; Sheffield, CL; White, DG; Zhao, S1
Badal, RE; Cao, B; Chen, S; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Z; Huang, W; Kong, H; Liao, K; Luo, Y; Ni, Y; Shao, H; Su, J; Sun, Z; Wang, Y; Wu, A; Xu, Y; Yang, Q; Yu, Y; Zhang, H; Zhang, S1
Baker-Austin, C; Fletcher, DE; McArthur, JV; Tuckfield, RC1
Galarza, P; Gianecini, R; Guantay, C; Oviedo, C; Piccoli, L; Stafforini, G1
Davies, HA; Garamus, VM; Gorniak, T; Hilpert, K; Mikut, R; Reischl, M; Rosenhahn, A; von Gundlach, AR1
Ammenouche, N; Castelain, S; Choquet, M; Decroix, V; Guiheneuf, R; Pluquet, E1
Brul, S; Feng, Y; Jonker, MJ; Moustakas, I; Ter Kuile, BH1
Banerjee, R; Boyce, TG; Cunningham, SA; Hasassri, ME; Jeraldo, PR; Kaye, KS; Norgan, AP; Patel, R; Pogue, JM; Weissman, SJ1
Álvarez, C; Ardila, N; Ariza, B; Caro, MA; Gil, F; González, PF; Valderrama, SL1
Abdel-Haq, N; Ang, JY; Nicolau, DP; Satlin, MJ; Thabit, AK; van Duin, D; Zhu, F1
Barkham, TM; Chen, H; Gin, KY; Koh, TH; Le, TH; Ng, C; Yi, XZ; Zhou, Z1
Bader, M; Seitz, M; Stief, C; Tilki, D; Waidelich, R1
Ha, DT; Ho-Le, TP; Hoang, HQ; Nguyen, DA; Nguyen, TA; Nguyen, TSM; Nguyen, TV; Pham, TTN; Tran, GM; Tran, NV; Tran-Nguyen, CH1
Coll, P; Espinal, P; Gómez, L; Miró, E; Navarro, F; Plasencia, V; Segura, C1
Auerbach, AD; Dvorak, CC; Levy, ER; Sabnis, AJ; Wattier, RL1
Chen, CJ; Chuang, YY; Huang, YC; Ko, WC; Lauderdale, TY; Lee, CY; Lu, CT; Lu, MC; Wu, TS; Yang, CC1
Fung, CP; Lin, YT; Wang, FD; Wu, PF; Yang, TC1
Caetano, T; Covas, C; Mendo, S; Santos, T; Viana, AT1
McLaughlin, HP; Sue, D1
Nakagawa, Y; Sai, Y; Shimada, T; Suga, Y; Suzuki, T1
Kaur, S; Rashid, M; Sharma, P1
Ariza, J; Benavent, E; Cabo, X; Gómez-Junyent, J; Murillo, O; Padullés, A; Rigo-Bonnin, R; Soldevila, L; Tubau, F1
Gillani, SSA; Kanwal, Z; Malik, H; Pervaiz, I; Rafique, M; Rashid, F1
Carolan, JC; Margalit, A; Walsh, F1
Abaza, M; Aboubakr, M; Awad, D; Edris, S; Fouad, M; Hamad, A; Hussein, A; Nabil, M; Ramadan, H; Sabeq, I; Shama, S1
Abdulla, A; Bahmany, S; Endeman, H; Ewoldt, TMJ; Gommers, D; Hunfeld, N; Koch, BCP; Muller, AE; Polinder, S; Spronk, I; van den Broek, P1
Goytia, M; Wadsworth, CB1
Alispahic, IA; Andreassen, HF; Armbruster, K; Bangsborg, J; Bodtger, U; Browatzki, A; Christensen, CW; Coia, JE; Datcu, R; Eklöf, J; Ellingsgaard, T; Fenlev, CS; Ghathian, KSA; Gundersen, L; Harboe, ZB; Heidemann, M; Janner, J; Jensen, JUS; Jensen, TT; Johansson, SL; Johnsen, S; Kjærgaard, JL; Lapperre, TS; Linde, H; Moberg, M; Nielsen, TL; Overgaard, RH; Pedersen, L; Rosenvinge, FS; Saeed, MI; Seersholm, N; Sivapalan, P; Sørensen, VM; Titlestad, I; Ulrik, CS; Vijdea, R; Weinreich, UM; Wilcke, T; Østergaard, C1
Bower, WA; Bulitta, JB; Chatham-Stephens, K; Cook, R; Hendricks, K; Kennedy, JL; Mongkolrattanothai, T; Negron, ME; Person, MK; Shin, E; Yu, P1
Abdulla, A; de Winter, BCM; Draisma, A; Endeman, H; Ewoldt, TMJ; Gommers, D; Haringman, J; Hunfeld, NGM; Karakus, A; Koch, BCP; Muller, AE; Purmer, IM; Rietdijk, WJR; Rijpstra, TA; van Vliet, P; Wils, EJ1
Kepiro, I; Pagliara, S; Ryadnov, MG; Zhang, Y1
Angelov, A; Bohn, E; Borisova, M; Eggers, O; Egle, V; Engesser, C; Klein, K; Mayer, C; Michalek, LA; Renschler, FA; Schütz, M; Smollich, F; Sonnabend, MS; Wackler, N; Walter, E1
Aydiner, C; Ikizoglu, B; Kanat, G; Turkdogan, FI1
Braetz, S; Figueroa-Bossi, N; Fulde, M; Schwerk, P; Tedin, K1

Reviews

6 review(s) available for beta-lactams and ciprofloxacin

ArticleYear
Ciprofloxacin vs an aminoglycoside in combination with a beta-lactam for the treatment of febrile neutropenia: a meta-analysis of randomized controlled trials.
    Mayo Clinic proceedings, 2005, Volume: 80, Issue:9

    Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Drug Therapy, Combination; Fever; Humans; Neoplasms; Neutropenia; Randomized Controlled Trials as Topic; Treatment Outcome

2005
Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis.
    Clinical pharmacokinetics, 2006, Volume: 45, Issue:8

    Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; beta-Lactams; Ciprofloxacin; Critical Care; Drug Administration Schedule; Drug Monitoring; Humans; Sepsis; Vancomycin

2006
Ciprofloxacin/metronidazole versus beta-lactam-based treatment of intra-abdominal infections: a meta-analysis of comparative trials.
    International journal of antimicrobial agents, 2006, Volume: 28, Issue:3

    Topics: Abdomen; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Ciprofloxacin; Drug Therapy, Combination; Humans; Metronidazole; PubMed; Randomized Controlled Trials as Topic

2006
Antibiotic drug interactions.
    The Medical clinics of North America, 2006, Volume: 90, Issue:6

    Topics: Aminoglycosides; Anti-Bacterial Agents; Antitubercular Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; beta-Lactams; Chloramphenicol; Ciprofloxacin; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Fluoroquinolones; Gastrointestinal Tract; Histamine H2 Antagonists; Humans; Influenza A virus; Macrolides; Pharmacokinetics; Tetracyclines

2006
Canary in the Coal Mine: How Resistance Surveillance in Commensals Could Help Curb the Spread of AMR in Pathogenic
    mBio, 2022, 10-26, Volume: 13, Issue:5

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; beta-Lactams; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria; Neisseria gonorrhoeae; Penicillin-Binding Proteins

2022
Postexposure Prophylaxis and Treatment of Bacillus anthracis Infections: A Systematic Review and Meta-analyses of Animal Models, 1947-2019.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022, 10-17, Volume: 75, Issue:Suppl 3

    Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anthrax; Anti-Bacterial Agents; Anti-Infective Agents; Bacillus anthracis; beta-Lactams; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Doxycycline; Glycopeptides; Humans; Levofloxacin; Lipopeptides; Models, Animal; Tetracyclines; United States

2022

Trials

7 trial(s) available for beta-lactams and ciprofloxacin

ArticleYear
Resistance to beta-lactam antibiotics and ciprofloxacin in gram-negative bacilli and staphylococci isolated from blood: a European collaborative study. European Study Group on Antibiotic Resistance.
    The Journal of antimicrobial chemotherapy, 1990, Volume: 26, Issue:2

    Topics: Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Drug Resistance, Microbial; Escherichia coli; Europe; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Pseudomonas; Staphylococcus aureus

1990
Comparison of ciprofloxacin and beta-lactam antibiotics in the treatment of urinary tract infections and alteration of fecal flora.
    The American journal of medicine, 1987, Apr-27, Volume: 82, Issue:4A

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Ciprofloxacin; Clinical Trials as Topic; Drug Resistance, Microbial; Feces; Female; Gram-Negative Aerobic Bacteria; Humans; Intestines; Male; Middle Aged; Urinary Tract Infections

1987
[Ciprofloxacin after clinical failure of beta-lactam antibiotics in children with salmonellosis].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2003, Volume: 10, Issue:7

    Topics: Administration, Oral; Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Microbial; Female; Humans; Infant; Male; Salmonella Infections; Treatment Outcome

2003
Treatment duration of febrile urinary tract infection (FUTIRST trial): a randomized placebo-controlled multicenter trial comparing short (7 days) antibiotic treatment with conventional treatment (14 days).
    BMC infectious diseases, 2009, Aug-19, Volume: 9

    Topics: Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Double-Blind Method; Female; Fever; Gentamicins; Humans; Male; Urinary Tract Infections

2009
Effective antimicrobial stewardship in a long-term care facility through an infectious disease consultation service: keeping a LID on antibiotic use.
    Infection control and hospital epidemiology, 2012, Volume: 33, Issue:12

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Ciprofloxacin; Clindamycin; Clostridioides difficile; Enterocolitis, Pseudomembranous; Humans; Infectious Disease Medicine; Long-Term Care; Nitrofurantoin; Nursing Homes; Referral and Consultation; Regression Analysis; Tetracyclines; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin

2012
Targeted AntiBiotics for Chronic pulmonary diseases (TARGET ABC): can targeted antibiotic therapy improve the prognosis of Pseudomonas aeruginosa-infected patients with chronic pulmonary obstructive disease, non-cystic fibrosis bronchiectasis, and asthma?
    Trials, 2022, Sep-27, Volume: 23, Issue:1

    Topics: Anti-Bacterial Agents; Asthma; beta-Lactams; Bronchiectasis; Ciprofloxacin; Fibrosis; Humans; Prednisolone; Prognosis; Pseudomonas aeruginosa; Pulmonary Disease, Chronic Obstructive

2022
Model-informed precision dosing of beta-lactam antibiotics and ciprofloxacin in critically ill patients: a multicentre randomised clinical trial.
    Intensive care medicine, 2022, Volume: 48, Issue:12

    Topics: Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Critical Illness; Humans; Intensive Care Units; Middle Aged; Monobactams

2022

Other Studies

91 other study(ies) available for beta-lactams and ciprofloxacin

ArticleYear
Killing curve activity of ciprofloxacin is comparable to synergistic effect of beta-lactam-tobramycin combinations against Haemophilus species endocarditis strains.
    APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 1992, Volume: 100, Issue:9

    Topics: Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Drug Synergism; Endocarditis, Bacterial; Haemophilus; Humans; Microbial Sensitivity Tests; Tobramycin

1992
Protection of Pseudomonas aeruginosa against ciprofloxacin and beta-lactams by homologous alginate.
    Antimicrobial agents and chemotherapy, 1991, Volume: 35, Issue:11

    Topics: Alginates; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Cystic Fibrosis; Humans; Microbial Sensitivity Tests; Polysaccharides; Pseudomonas aeruginosa

1991
[In vitro activity of 4 fluoroquinolones against Klebsiella pneumoniae. Distribution according to phenotype resistance to aminoglycosides or beta-lactams].
    Pathologie-biologie, 1990, Volume: 38, Issue:5

    Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; In Vitro Techniques; Klebsiella pneumoniae; Norfloxacin; Ofloxacin; Pefloxacin; Phenotype

1990
[In vitro effect of various antibiotics: beta lactams, aminoglycosides and fluoroquinolones alone and in combination against P. aeruginosa isolated from patients with mucoviscidosis].
    Pathologie-biologie, 1989, Volume: 37, Issue:5 Pt 2

    Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Cystic Fibrosis; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Ofloxacin; Pseudomonas aeruginosa

1989
Cross-resistance of Pseudomonas aeruginosa to ciprofloxacin, extended-spectrum beta-lactams, and aminoglycosides and susceptibility to antibiotic combinations.
    Antimicrobial agents and chemotherapy, 1989, Volume: 33, Issue:8

    Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Ciprofloxacin; Drug Resistance, Microbial; Drug Therapy, Combination; Microbial Sensitivity Tests; Pseudomonas aeruginosa

1989
In-vitro activity of FCE 22101 and synergy studies with other antimicrobial agents.
    The Journal of antimicrobial chemotherapy, 1989, Volume: 23 Suppl C

    Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Ciprofloxacin; Drug Resistance, Microbial; Drug Synergism; Gentamicins; Gram-Positive Bacteria; Microbial Sensitivity Tests

1989
In vitro susceptibility of strains of Pseudomonas pseudomallei isolated in Thailand and Hong Kong to some newer beta-lactam antibiotics and quinolone derivatives.
    The Journal of infectious diseases, 1986, Volume: 153, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Hong Kong; Humans; Microbial Sensitivity Tests; Ofloxacin; Oxazines; Pseudomonas; Quinolines; Thailand

1986
Comprehensive evaluation of ciprofloxacin in combination with beta-lactam antibiotics against Enterobacteriaceae and Pseudomonas aeruginosa.
    Arzneimittel-Forschung, 1986, Volume: 36, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Ciprofloxacin; Drug Synergism; Enterobacteriaceae; Male; Mice; Muscles; Pseudomonas aeruginosa; Quinolines; Time Factors

1986
In vitro activity of aryl fluoroquinolones, Abbott 56619 and Abbott 56620, compared to ciprofloxacin, norfloxacin and beta-lactams versus multidrug-resistant Enterobacteriaceae and Pseudomonas aeruginosa.
    Chemotherapy, 1986, Volume: 32, Issue:5

    Topics: Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Enterobacteriaceae; Fluoroquinolones; Microbial Sensitivity Tests; Norfloxacin; Pseudomonas aeruginosa

1986
Comparison of the bactericidal activity of ciprofloxacin alone and in combination with selected antipseudomonal beta-lactam agents against clinical isolates of Pseudomonas aeruginosa.
    Diagnostic microbiology and infectious disease, 1988, Volume: 11, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Drug Stability; Drug Synergism; Drug Therapy, Combination; Kinetics; Microbial Sensitivity Tests; Pseudomonas aeruginosa

1988
In vitro synergy studies with ciprofloxacin and selected beta-lactam agents and aminoglycosides against multidrug-resistant Pseudomonas aeruginosa.
    Diagnostic microbiology and infectious disease, 1988, Volume: 11, Issue:3

    Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Drug Resistance, Microbial; Drug Synergism; Microbial Sensitivity Tests; Pseudomonas aeruginosa

1988
Synergistic interactions of ciprofloxacin and extended spectrum beta-lactams or aminoglycosides against Acinetobacter calcoaceticus ss. anitratus.
    Diagnostic microbiology and infectious disease, 1988, Volume: 9, Issue:4

    Topics: Acinetobacter; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Drug Synergism; Humans; Microbial Sensitivity Tests

1988
Influence of beta-lactam antibiotics and ciprofloxacin on cell envelope of Escherichia coli.
    Antimicrobial agents and chemotherapy, 1987, Volume: 31, Issue:7

    Topics: Amino Acids; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Capsules; beta-Lactams; Cell Membrane; Ciprofloxacin; Diaminopimelic Acid; Escherichia coli; Lipid Metabolism; Phospholipids; Polysaccharides, Bacterial; Sugar Acids

1987
Synergistic interactions of ciprofloxacin and extended-spectrum beta-lactams or aminoglycosides against multiply drug-resistant Pseudomonas maltophilia.
    Antimicrobial agents and chemotherapy, 1988, Volume: 32, Issue:5

    Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Drug Resistance, Microbial; Drug Synergism; Humans; Microbial Sensitivity Tests; Pseudomonas

1988
Influence of beta-lactam antibiotics and ciprofloxacin on composition and immunogenicity of Escherichia coli outer membrane.
    Antimicrobial agents and chemotherapy, 1986, Volume: 30, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Antibody-Producing Cells; beta-Lactams; Cell Membrane; Centrifugation, Density Gradient; Ciprofloxacin; Escherichia coli; Hemolytic Plaque Technique; Lipopolysaccharides; Mice; Microbial Sensitivity Tests; Phospholipids

1986
Susceptibilities of 123 strains of Xanthomonas maltophilia to eight beta-lactams (including beta-lactam-beta-lactamase inhibitor combinations) and ciprofloxacin tested by five methods.
    Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:10

    Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Ciprofloxacin; Drug Resistance, Microbial; Microbial Sensitivity Tests; Xanthomonas

1994
Comparison of susceptibility to extended-spectrum beta-lactam antibiotics and ciprofloxacin among gram-negative bacilli isolated from intensive care units.
    Diagnostic microbiology and infectious disease, 1995, Volume: 22, Issue:3

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Microbial Sensitivity Tests

1995
In vitro activity of the tricyclic beta-lactam GV104326.
    Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:5

    Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Cefuroxime; Ciprofloxacin; Haemophilus influenzae; Lactams; Microbial Sensitivity Tests; Moraxella catarrhalis; Streptococcus pneumoniae

1996
[Pseudomonas aeruginosa: bactericidal activity on various beta-lactam resistance phenotypes of 8 antibiotics and 7 combinations].
    Pathologie-biologie, 1997, Volume: 45, Issue:5

    Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactam Resistance; beta-Lactams; Ciprofloxacin; Drug Therapy, Combination; In Vitro Techniques; Phenotype; Pseudomonas aeruginosa

1997
Activity of selected beta-lactams, ciprofloxacin, and amikacin against different Acinetobacter baumannii biotypes from Chilean hospitals.
    Diagnostic microbiology and infectious disease, 1997, Volume: 28, Issue:4

    Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactams; Chile; Ciprofloxacin; Cross Infection; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Multicenter Studies as Topic

1997
Susceptibility to new beta-lactams of enterobacterial extended-spectrum beta-lactamase (ESBL) producers and penicillin-resistant Streptococcus pneumoniae in Mexico.
    Journal of chemotherapy (Florence, Italy), 1998, Volume: 10, Issue:2

    Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; beta-Lactams; Cephalosporin Resistance; Ciprofloxacin; Colony Count, Microbial; Enterobacteriaceae; Mexico; Penicillin Resistance; Streptococcus pneumoniae

1998
In vitro activity of ciprofloxacin, levofloxacin, and trovafloxacin, alone and in combination with beta-lactams, against clinical isolates of Pseudomonas aeruginosa, Stenotrophomonas maltophilia, and Burkholderia cepacia.
    Diagnostic microbiology and infectious disease, 1999, Volume: 33, Issue:2

    Topics: Anti-Infective Agents; beta-Lactams; Burkholderia cepacia; Ciprofloxacin; Fluoroquinolones; Humans; Levofloxacin; Naphthyridines; Ofloxacin; Pseudomonas aeruginosa; Xanthomonas

1999
[In vitro activity of fluoroquinolones and oral beta lactam antibiotics against clinical isolates of Escherichia coli].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 1999, Volume: 12, Issue:1

    Topics: Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Ciprofloxacin; Escherichia coli; Fluoroquinolones; Humans; Microbial Sensitivity Tests

1999
Comparative antimicrobial activity of gatifloxacin with ciprofloxacin and beta-lactams against gram-positive bacteria.
    Diagnostic microbiology and infectious disease, 2001, Volume: 41, Issue:3

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Ciprofloxacin; Enterococcus; Fluoroquinolones; Gatifloxacin; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Staphylococcus; Streptococcus

2001
Ciprofloxacin as broad-spectrum empiric therapy--are fluoroquinolones still viable monotherapeutic agents compared with beta-lactams: data from the MYSTIC Program (US)?
    Diagnostic microbiology and infectious disease, 2002, Volume: 42, Issue:3

    Topics: Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; United States

2002
Comparative intracellular (THP-1 macrophage) and extracellular activities of beta-lactams, azithromycin, gentamicin, and fluoroquinolones against Listeria monocytogenes at clinically relevant concentrations.
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:7

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Azithromycin; beta-Lactams; Ciprofloxacin; Fluoroquinolones; Gentamicins; Humans; Listeria monocytogenes; Macrophages; Microbial Sensitivity Tests; Moxifloxacin; Quinolines

2002
Comparative in vitro activities of ertapenem against aerobic and facultative bacterial pathogens from patients with complicated skin and skin structure infections.
    Diagnostic microbiology and infectious disease, 2002, Volume: 43, Issue:2

    Topics: Aerobiosis; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Ertapenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Lactams; Microbial Sensitivity Tests; Skin Diseases, Bacterial

2002
Antianaerobic activity of moxifloxacin compared with that of ofloxacin, ciprofloxacin, clindamycin, metronidazole and beta-lactams.
    International journal of antimicrobial agents, 2002, Volume: 20, Issue:5

    Topics: Anaerobiosis; Anti-Bacterial Agents; Aza Compounds; Bacterial Infections; beta-Lactams; Ciprofloxacin; Clindamycin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines

2002
Activity of faropenem and imipenem for ciprofloxacin-resistant bacteria.
    The Journal of antimicrobial chemotherapy, 2003, Volume: 52, Issue:3

    Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Imipenem; Lactams; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Phenotype; Reverse Transcriptase Polymerase Chain Reaction; Thienamycins

2003
Efficacy of amikacin combinations for nocardiosis.
    The Tohoku journal of experimental medicine, 2003, Volume: 201, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Ciprofloxacin; DNA, Ribosomal; Drug Therapy, Combination; Erythromycin; Female; Fluoroquinolones; Gram-Positive Bacteria; Humans; Imipenem; Lactams; Male; Middle Aged; Minocycline; Nocardia; Nocardia Infections; RNA, Ribosomal, 16S; Streptomyces; Sulfamethoxazole; Trimethoprim

2003
[E. coli: resistance to quinolones and beta-lactams of clinical strains isolated in the Franche-Comté region of France].
    Pathologie-biologie, 2004, Volume: 52, Issue:2

    Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Ceftazidime; Cephalothin; Ciprofloxacin; Clavulanic Acid; Community-Acquired Infections; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Utilization; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; France; Genotype; Humans; Male; Middle Aged; Nalidixic Acid; Phenotype; Selection, Genetic; Urinary Tract Infections

2004
Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates.
    International journal of antimicrobial agents, 2004, Volume: 24, Issue:6

    Topics: Aztreonam; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cephalosporins; Ciprofloxacin; Enterobacteriaceae; Enterobacteriaceae Infections; Europe; Humans; Klebsiella; Klebsiella Infections; Microbial Sensitivity Tests

2004
Pharmacodynamic modeling of carbapenems and fluoroquinolones against bacteria that produce extended-spectrum beta-lactamases.
    Clinical therapeutics, 2004, Volume: 26, Issue:11

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Ciprofloxacin; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Fluoroquinolones; Gatifloxacin; Humans; Imipenem; Klebsiella pneumoniae; Lactams; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Models, Biological; Monte Carlo Method; Ofloxacin; Thienamycins

2004
Stable antimicrobial susceptibility rates for clinical isolates of Pseudomonas aeruginosa from the 2001-2003 tracking resistance in the United States today surveillance studies.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Feb-15, Volume: 40 Suppl 2

    Topics: beta-Lactams; Ceftazidime; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gatifloxacin; Gentamicins; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; United States

2005
In vitro selection of resistance in Pseudomonas aeruginosa and Acinetobacter spp. by levofloxacin and ciprofloxacin alone and in combination with beta-lactams and amikacin.
    The Journal of antimicrobial chemotherapy, 2005, Volume: 56, Issue:2

    Topics: Acinetobacter; Amikacin; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Levofloxacin; Microbial Sensitivity Tests; Mutation; Ofloxacin; Pseudomonas aeruginosa

2005
Systematic reviews and meta-analysis of febrile neutropenia.
    Mayo Clinic proceedings, 2005, Volume: 80, Issue:9

    Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Drug Therapy, Combination; Fever; Humans; Meta-Analysis as Topic; Neoplasms; Neutropenia; Reproducibility of Results; Review Literature as Topic; Treatment Outcome

2005
Ciprofloxacin, salicylate, and 2,4-dinitrophenol decrease production of AmpC-type beta-lactamase in two Citrobacter freundii clinical isolates.
    Microbial drug resistance (Larchmont, N.Y.), 2005,Fall, Volume: 11, Issue:3

    Topics: 2,4-Dinitrophenol; beta-Lactamases; beta-Lactams; Ciprofloxacin; Citrobacter freundii; Drug Resistance, Bacterial; Enzyme Induction; Humans; Salicylates

2005
Factor V inhibitor: case report.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2006, Volume: 17, Issue:7

    Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Blood Coagulation Tests; Ciprofloxacin; Disease Progression; Factor V; Humans; Immunosuppressive Agents; Intracranial Hemorrhages; Lung Diseases; Male; Postoperative Complications

2006
Safety and effectiveness of a preoperative allergy clinic in decreasing vancomycin use in patients with a history of penicillin allergy.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2006, Volume: 97, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Cefazolin; Ceftriaxone; Cephalosporins; Ciprofloxacin; Clindamycin; Critical Pathways; Drug Hypersensitivity; Female; Humans; Male; Middle Aged; Penicillins; Preoperative Care; Skin Tests; Treatment Outcome; Vancomycin

2006
[Bilophila wadsworthia isolated from surgical specimens].
    The Japanese journal of antibiotics, 2006, Volume: 59, Issue:6

    Topics: Anti-Bacterial Agents; beta-Lactams; Bilophila; Ciprofloxacin; Clindamycin; Digestive System Surgical Procedures; Drug Resistance, Bacterial; Humans; Japan; Levofloxacin; Minocycline; Ofloxacin; Peritonitis; Postoperative Complications; Specimen Handling; Surgical Wound Infection

2006
In vitro synergism of beta-lactams with ciprofloxacin and moxifloxacin against genetically distinct multidrug-resistant isolates of Pseudomonas aeruginosa.
    International journal of antimicrobial agents, 2008, Volume: 32, Issue:1

    Topics: Anti-Bacterial Agents; Aza Compounds; beta-Lactams; Ciprofloxacin; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Synergism; Electrophoresis, Gel, Pulsed-Field; Fluoroquinolones; Microbial Viability; Moxifloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines; Time Factors

2008
Expansion and countrywide dissemination of ST11, ST15 and ST147 ciprofloxacin-resistant CTX-M-15-type beta-lactamase-producing Klebsiella pneumoniae epidemic clones in Hungary in 2005--the new 'MRSAs'?
    The Journal of antimicrobial chemotherapy, 2008, Volume: 62, Issue:5

    Topics: Adult; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Ciprofloxacin; Cluster Analysis; Conjugation, Genetic; Cross Infection; Disease Outbreaks; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genotype; Humans; Hungary; Klebsiella Infections; Klebsiella pneumoniae; Molecular Epidemiology; Plasmids; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Sequence Analysis, DNA

2008
[Optimization of antibiotics in combination].
    Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns, 2008, Volume: 24, Issue:2

    Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Burn Units; Ciprofloxacin; Drug Therapy, Combination; Humans; Intensive Care Units; Microbial Sensitivity Tests; Pseudomonas aeruginosa

2008
Evidence for qnrB1 and aac(6')-Ib-cr in CTX-M-15-producing uropathogenic Enterobacteriaceae in an Italian teaching hospital.
    Diagnostic microbiology and infectious disease, 2009, Volume: 64, Issue:1

    Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Gene Order; Genes, Bacterial; Hospitals, Teaching; Humans; Italy; Urinary Tract Infections

2009
Subinhibitory fluoroquinolone exposure selects for reduced beta-lactam susceptibility in methicillin-resistant Staphylococcus aureus and alterations in the SOS-mediated response.
    Research in microbiology, 2009, Volume: 160, Issue:3

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactams; Ciprofloxacin; Community-Acquired Infections; DNA Gyrase; DNA Mutational Analysis; DNA Transposable Elements; Fluoroquinolones; Gene Expression Profiling; Humans; Levofloxacin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nafcillin; Ofloxacin; Penicillin-Binding Proteins; Selection, Genetic; SOS Response, Genetics; Staphylococcal Infections; Transcription Factors; Up-Regulation

2009
Previous ciprofloxacin exposure is associated with resistance to beta-lactam antibiotics in subsequent Pseudomonas aeruginosa bacteremic isolates.
    American journal of infection control, 2009, Volume: 37, Issue:9

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactams; Ciprofloxacin; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Young Adult

2009
Nursing homes as a reservoir of extended-spectrum beta-lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia coli.
    The Journal of antimicrobial chemotherapy, 2009, Volume: 64, Issue:3

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carrier State; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Feces; Female; Humans; Male; Northern Ireland; Nursing Homes; Prevalence

2009
Activity of amikacin, ertapenem, ciprofloxacin and levofloxacin alone and in combination against resistant nosocomial pathogens by time-kill.
    The West Indian medical journal, 2008, Volume: 57, Issue:2

    Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Cross Infection; Drug Synergism; Drug Therapy, Combination; Ertapenem; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin

2008
Outbreaks of imipenem resistant Acinetobacter baumannii producing OXA-23 beta-lactamase in a tertiary care hospital in Korea.
    Yonsei medical journal, 2009, Dec-31, Volume: 50, Issue:6

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Ciprofloxacin; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gentamicins; Humans; Imipenem; Korea; Microbial Sensitivity Tests

2009
Rapidly spreading CTX-M-type beta-lactamase-producing Proteus mirabilis in Japan.
    International journal of antimicrobial agents, 2010, Volume: 36, Issue:4

    Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Japan; Microbial Sensitivity Tests; Molecular Epidemiology; Polymerase Chain Reaction; Prevalence; Proteus Infections; Proteus mirabilis; Quinolones; Sequence Analysis, DNA; Time Factors

2010
Antimicrobial susceptibility of Neisseria meningitidis strains isolated from meningitis cases in Brazil from 2006 to 2008.
    Enfermedades infecciosas y microbiologia clinica, 2011, Volume: 29, Issue:2

    Topics: Adolescent; Adult; Anti-Bacterial Agents; beta-Lactams; Brazil; Child; Child, Preschool; Chloramphenicol; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Humans; Infant; Male; Meningitis, Meningococcal; Microbial Sensitivity Tests; Neisseria meningitidis; Rifampin; Serotyping; Species Specificity; Young Adult

2011
Drug induced immune haemolytic anaemia in the Berlin Case-Control Surveillance Study.
    British journal of haematology, 2011, Volume: 154, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia, Hemolytic, Autoimmune; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Berlin; beta-Lactams; Case-Control Studies; Ciprofloxacin; Diclofenac; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Lorazepam; Male; Middle Aged; Odds Ratio; Piperacillin; Population Surveillance; Trimethoprim, Sulfamethoxazole Drug Combination; Vidarabine; Young Adult

2011
Development of carbapenem resistance during therapy for non-typhoid Salmonella infection.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2012, Volume: 18, Issue:4

    Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Ertapenem; Feces; Female; Humans; Microbial Sensitivity Tests; Plasmids; Point Mutation; Porins; RNA, Bacterial; Salmonella Infections; Salmonella typhimurium; Urinary Tract Infections; Wound Infection

2012
Comparison of the WST-8 colorimetric method and the CLSI broth microdilution method for susceptibility testing against drug-resistant bacteria.
    Journal of microbiological methods, 2012, Volume: 90, Issue:3

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Ciprofloxacin; Colorimetry; Culture Media; Enterococcus faecalis; Haemophilus influenzae; Indicator Dilution Techniques; Klebsiella pneumoniae; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Microbial Viability; Pseudomonas aeruginosa; Vancomycin; Vancomycin Resistance

2012
Integrons, β-lactamase and qnr genes in multidrug resistant clinical isolates of Proteus mirabilis and P. vulgaris.
    APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 2012, Volume: 120, Issue:12

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gentamicins; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Proteus mirabilis; Proteus vulgaris; Sequence Analysis, DNA; Sulfamethoxazole; Trimethoprim, Sulfamethoxazole Drug Combination

2012
Impact of ertapenem use on Pseudomonas aeruginosa and Acinetobacter baumannii imipenem susceptibility rates: collateral damage or positive effect on hospital ecology?
    The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:8

    Topics: Acinetobacter baumannii; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Ciprofloxacin; Cross Infection; Drug Utilization; Ecosystem; Ertapenem; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Retrospective Studies; Selection, Genetic; Tertiary Care Centers

2013
Sublethal ciprofloxacin treatment leads to rapid development of high-level ciprofloxacin resistance during long-term experimental evolution of Pseudomonas aeruginosa.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:9

    Topics: Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; DNA Gyrase; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Mutation; Pseudomonas aeruginosa; Sequence Analysis, DNA

2013
Activity of the antiseptic polyhexanide against gram-negative bacteria.
    Microbial drug resistance (Larchmont, N.Y.), 2014, Volume: 20, Issue:2

    Topics: Anti-Bacterial Agents; Anti-Infective Agents, Local; beta-Lactams; Biguanides; Ciprofloxacin; Drug Combinations; Escherichia coli; Gentamicins; Haemophilus influenzae; Klebsiella pneumoniae; Microbial Sensitivity Tests; Microbial Viability; Moraxella catarrhalis; Pseudomonas aeruginosa

2014
Risk factors associated with preoperative fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in liver transplant recipients.
    Transplant infectious disease : an official journal of the Transplantation Society, 2014, Volume: 16, Issue:1

    Topics: Adult; Amikacin; beta-Lactamases; beta-Lactams; Cefoxitin; Ciprofloxacin; Drug Resistance, Bacterial; End Stage Liver Disease; Enterobacter cloacae; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Feces; Female; Humans; Imipenem; Klebsiella; Klebsiella Infections; Klebsiella pneumoniae; Liver Transplantation; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Preoperative Period; Risk Factors; Severity of Illness Index

2014
Ertapenem prophylaxis reduces sepsis after transrectal biopsy of the prostate.
    BJU international, 2014, Volume: 113 Suppl 2

    Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Biopsy; Ciprofloxacin; Drug Therapy, Combination; Ertapenem; Escherichia coli Infections; Humans; Male; Middle Aged; Patient Selection; Prospective Studies; Prostatic Neoplasms; Rectum; Risk Assessment; Risk Factors; Sepsis; Surveys and Questionnaires; Treatment Outcome; Ultrasonography, Interventional

2014
Multidrug-resistant Escherichia coli soft tissue infection investigated with bacterial whole genome sequencing.
    BMJ case reports, 2014, Oct-19, Volume: 2014

    Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Diagnosis, Differential; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Floxacillin; Follow-Up Studies; Genome, Bacterial; Gentamicins; Humans; Liver Diseases; Male; Meropenem; Middle Aged; Sequence Analysis, DNA; Soft Tissue Infections; Thienamycins; Treatment Outcome; Vancomycin

2014
Characterization of antibiotic and disinfectant susceptibility profiles among Pseudomonas aeruginosa veterinary isolates recovered during 1994-2003.
    Journal of applied microbiology, 2015, Volume: 118, Issue:2

    Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Disinfectants; Dogs; Drug Resistance, Bacterial; Enrofloxacin; Fluoroquinolones; Pseudomonas aeruginosa

2015
Antimicrobial Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli from Intra-abdominal Infections in Patients from Seven Regions in China in 2012 and 2013.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1

    Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefoxitin; China; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Gene Expression; Humans; Imipenem; Intraabdominal Infections; Levofloxacin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam

2016
Patterns of Multi-Antibiotic-Resistant Escherichia Coli from Streams with No History of Antimicrobial Inputs.
    Microbial ecology, 2016, Volume: 72, Issue:4

    Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Ciprofloxacin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Escherichia coli; Fluoroquinolones; Gatifloxacin; Geologic Sediments; Microbial Sensitivity Tests; Rivers; Water Microbiology

2016
Prevalence of bla TEM-220 gene in Penicillinase-producing Neisseria gonorrhoeae strains carrying Toronto/Rio plasmid in Argentina, 2002 - 2011.
    BMC infectious diseases, 2015, Dec-16, Volume: 15

    Topics: Anti-Bacterial Agents; Argentina; beta-Lactamases; beta-Lactams; Ciprofloxacin; Humans; Microbial Sensitivity Tests; Mutation; Neisseria gonorrhoeae; Penicillinase; Plasmids; Prevalence

2015
Small angle X-ray scattering as a high-throughput method to classify antimicrobial modes of action.
    Biochimica et biophysica acta, 2016, Volume: 1858, Issue:5

    Topics: Aminoglycosides; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; beta-Lactams; Chloramphenicol; Ciprofloxacin; Drug Discovery; Escherichia coli K12; High-Throughput Screening Assays; Microscopy, Electron, Transmission; Polymyxin B; Principal Component Analysis; Rifampin; Scattering, Small Angle; Tetracycline; X-Ray Diffraction

2016
Place of diagnostic tools in the identification of Anaerobiospirillum succiniciproducens bacteraemia.
    Anaerobe, 2016, Volume: 39

    Topics: Anaerobiospirillum; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Clindamycin; Delayed Diagnosis; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pelvis; RNA, Ribosomal, 16S; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

2016
Dynamics of Mutations during Development of Resistance by Pseudomonas aeruginosa against Five Antibiotics.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:7

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Ceftazidime; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Microbial; Meropenem; Microbial Sensitivity Tests; Mutation; Piperacillin; Pseudomonas aeruginosa; Thienamycins; Tobramycin

2016
An Immunocompromised Child with Bloodstream Infection Caused by Two Escherichia coli Strains, One Harboring NDM-5 and the Other Harboring OXA-48-Like Carbapenemase.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:6

    Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactamases; beta-Lactams; Ciprofloxacin; Ertapenem; Escherichia coli; Female; Gentamicins; Humans; Immunocompromised Host; Meropenem; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam; Thienamycins; Tobramycin

2016
Risk factors for hospital-acquired bacteremia due to carbapenem-resistant Pseudomonas aeruginosa in a Colombian hospital.
    Biomedica : revista del Instituto Nacional de Salud, 2016, Feb-23, Volume: 36, Issue:0

    Topics: Bacteremia; beta-Lactams; Carbapenems; Case-Control Studies; Ciprofloxacin; Drug Resistance, Bacterial; Ertapenem; Hospitals; Humans; Meropenem; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Thienamycins

2016
Multidrug-Resistant Pseudomonas aeruginosa Infection in a Child with Cystic Fibrosis.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:10

    Topics: Adolescent; Amikacin; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Cystic Fibrosis; Drug Hypersensitivity; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam

2016
Occurrences and Characterization of Antibiotic-Resistant Bacteria and Genetic Determinants of Hospital Wastewater in a Tropical Country.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:12

    Topics: Amikacin; Anti-Bacterial Agents; Bacteria; beta-Lactamases; beta-Lactams; Chromatography, Liquid; Ciprofloxacin; Drug Resistance, Microbial; Escherichia coli Proteins; Hospitals; Humans; Integrases; Singapore; Tandem Mass Spectrometry; Trimethoprim, Sulfamethoxazole Drug Combination; Wastewater

2016
Transrectal ultrasound guided prostate biopsy in the era of increasing fluoroquinolone resistance: prophylaxis with single-dose ertapenem.
    World journal of urology, 2017, Volume: 35, Issue:11

    Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Biopsy, Large-Core Needle; Ciprofloxacin; Endosonography; Ertapenem; Humans; Image-Guided Biopsy; Male; Middle Aged; Prostate; Retrospective Studies; Surgical Wound Infection; Urinary Tract Infections

2017
Patterns of antimicrobial resistance in intensive care unit patients: a study in Vietnam.
    BMC infectious diseases, 2017, 06-15, Volume: 17, Issue:1

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; beta-Lactams; Ceftazidime; Ciprofloxacin; Drug Resistance, Bacterial; Ertapenem; Female; Humans; Imipenem; Intensive Care Units; Klebsiella; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections; Vietnam

2017
First Description of bla
    Microbial drug resistance (Larchmont, N.Y.), 2018, Volume: 24, Issue:2

    Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Gene Expression; Genes, Bacterial; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Pakistan; Plasmids; Spain; Travel

2018
Reducing Second Gram-Negative Antibiotic Therapy on Pediatric Oncology and Hematopoietic Stem Cell Transplantation Services.
    Infection control and hospital epidemiology, 2017, Volume: 38, Issue:9

    Topics: Adolescent; Anti-Bacterial Agents; Antimicrobial Stewardship; beta-Lactams; Child; Child, Preschool; Ciprofloxacin; Drug Combinations; Drug Utilization; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Guidelines as Topic; Hematopoietic Stem Cell Transplantation; Hospitals, Pediatric; Humans; Length of Stay; Medical Oncology; Neutropenia; Pediatrics; Poisson Distribution; San Francisco; Tobramycin; Treatment Outcome

2017
Clinical and molecular features of MDR livestock-associated MRSA ST9 with staphylococcal cassette chromosome mecXII in humans.
    The Journal of antimicrobial chemotherapy, 2018, Jan-01, Volume: 73, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Child, Preschool; Ciprofloxacin; Clindamycin; Drug Resistance, Multiple, Bacterial; Erythromycin; Farmers; Female; Gentamicins; Humans; Livestock; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Minocycline; Staphylococcal Infections; Swine; Swine Diseases; Taiwan; Tigecycline; Virginiamycin

2018
Is fluoroquinolone monotherapy a useful alternative treatment for Pseudomonas aeruginosa bacteraemia?
    Infection, 2018, Volume: 46, Issue:3

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Ciprofloxacin; Cohort Studies; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors; Taiwan; Treatment Outcome

2018
Environmental superbugs: The case study of Pedobacter spp.
    Environmental pollution (Barking, Essex : 1987), 2018, Volume: 241

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Ciprofloxacin; Drug Resistance, Microbial; Ertapenem; Escherichia coli; Humans; Meropenem; Microbial Sensitivity Tests; Pedobacter; Thienamycins

2018
Rapid antimicrobial susceptibility testing and β-lactam-induced cell morphology changes of Gram-negative biological threat pathogens by optical screening.
    BMC microbiology, 2018, 12-18, Volume: 18, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactams; Burkholderia mallei; Burkholderia pseudomallei; Ciprofloxacin; Doxycycline; Glanders; Humans; Imipenem; Melioidosis; Microbial Sensitivity Tests; Plague; Time-Lapse Imaging; Yersinia pestis

2018
Examination of Aggregate Formation upon Simultaneous Dissolution of Methacrylic Acid Copolymer LD Enteric Coating Agent, Pharmaceutical Additives, and Zwitterionic Ingredients.
    Biological & pharmaceutical bulletin, 2020, Volume: 43, Issue:4

    Topics: Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Drug Liberation; Ofloxacin; Polymethacrylic Acids; Static Electricity; Sulfur Compounds; Tablets, Enteric-Coated; Tegafur

2020
Novel enterocin E20c purified from Enterococcus hirae 20c synergised with ß-lactams and ciprofloxacin against Salmonella enterica.
    Microbial cell factories, 2020, May-04, Volume: 19, Issue:1

    Topics: Anti-Bacterial Agents; Bacteriocins; beta-Lactams; Bridged-Ring Compounds; Cell Membrane; Cell Membrane Permeability; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Enterococcus hirae; Gram-Negative Bacteria; Microbial Sensitivity Tests; Salmonella enterica

2020
Efficacy and Therapeutic Drug Monitoring of Continuous Beta-Lactam Infusion for Osteoarticular Infections Caused by Fluoroquinolone-Resistant Pseudomonas aeruginosa: A Prospective Cohort Study.
    European journal of drug metabolism and pharmacokinetics, 2020, Volume: 45, Issue:5

    Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Bone Diseases, Infectious; Ciprofloxacin; Cohort Studies; Colistin; Drug Monitoring; Drug Resistance, Multiple, Bacterial; Female; Humans; Infusions, Intravenous; Joint Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections

2020
Investigations on Synergistic and Antioxidant Actions of Medicinal Plant- Based Biosynthesis of Zinc Oxide Nanoparticles Against E.coli and K. pneumonia Bacteria.
    Combinatorial chemistry & high throughput screening, 2022, Volume: 25, Issue:7

    Topics: Anti-Bacterial Agents; Antioxidants; Bacteria; beta-Lactams; Ciprofloxacin; Escherichia coli; Metal Nanoparticles; Microbial Sensitivity Tests; Nanoparticles; Plant Extracts; Plants, Medicinal; Pneumonia; Zinc Oxide

2022
Global protein responses of multidrug resistance plasmid-containing Escherichia coli to ampicillin, cefotaxime, imipenem and ciprofloxacin.
    Journal of global antimicrobial resistance, 2022, Volume: 28

    Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; beta-Lactams; Cefotaxime; Ciprofloxacin; Drug Resistance, Multiple; Escherichia coli; Imipenem; Plasmids; Proteome; Proteomics

2022
Prevalence and molecular characterization of foodborne and human-derived Salmonella strains for resistance to critically important antibiotics.
    Transboundary and emerging diseases, 2022, Volume: 69, Issue:5

    Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Cattle; Cephalosporins; Ciprofloxacin; Colistin; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Monobactams; Prevalence; Rabbits; Salmonella; Salmonella enterica; Tetracyclines

2022
Barriers and facilitators for therapeutic drug monitoring of beta-lactams and ciprofloxacin in the ICU: a nationwide cross-sectional study.
    BMC infectious diseases, 2022, Jul-13, Volume: 22, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Cross-Sectional Studies; Drug Monitoring; Humans; Intensive Care Units

2022
Single Cell Killing Kinetics Differentiate Phenotypic Bacterial Responses to Different Antibacterial Classes.
    Microbiology spectrum, 2023, 02-14, Volume: 11, Issue:1

    Topics: Ampicillin; Anti-Bacterial Agents; Bacteria; beta-Lactams; Ciprofloxacin; Escherichia coli; Fluoroquinolones; Microbial Sensitivity Tests

2023
YgfB increases β-lactam resistance in Pseudomonas aeruginosa by counteracting AlpA-mediated ampDh3 expression.
    Communications biology, 2023, 03-10, Volume: 6, Issue:1

    Topics: beta-Lactam Resistance; beta-Lactams; Ciprofloxacin; Pseudomonas aeruginosa

2023
Seasonal analysis of commonly prescribed antibiotics in Istanbul city.
    Environmental monitoring and assessment, 2023, Apr-14, Volume: 195, Issue:5

    Topics: Anti-Bacterial Agents; beta-Lactams; Chromatography, Liquid; Ciprofloxacin; Clarithromycin; Environmental Monitoring; Seasons; Sewage; Solid Phase Extraction; Tandem Mass Spectrometry; Wastewater; Water Pollutants, Chemical

2023
Prophage Gifsy-1 Induction in Salmonella enterica Serovar Typhimurium Reduces Persister Cell Formation after Ciprofloxacin Exposure.
    Microbiology spectrum, 2023, 08-17, Volume: 11, Issue:4

    Topics: Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; DNA Gyrase; Prophages; Salmonella enterica; Salmonella typhimurium; Serogroup

2023